Related Experiment Video
Updated: Feb 19, 2026
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Readers of DNA methylation, the MBD family as potential therapeutic targets
Gordon D Ginder1, David C Williams2
1Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23298, United States; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, United States; Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, United States.
Abstract:
DNA methylation represents a fundamental epigenetic modification that regulates chromatin architecture and gene transcription. Many diseases, including cancer, show aberrant methylation patterns that contribute to the disease phenotype. DNA methylation inhibitors have been used to block methylation dependent gene silencing to treat hematopoietic neoplasms and to restore expression of developmentally silenced genes. However, these inhibitors disrupt methylation globally and show significant off-target toxicities. As an alternative approach, we have been studying readers of DNA methylation, the 5-methylcytosine binding domain family of proteins, as potential therapeutic targets to restore expression of aberrantly and developmentally methylated and silenced genes. In this review, we discuss the role of DNA methylation in gene regulation and cancer development, the structure and function of the 5-methylcytosine binding domain family of proteins, and the possibility of targeting the complexes these proteins form to treat human disease.
Insights
Aberrant DNA methylation drives cancer. Targeting 5-methylcytosine binding domain proteins offers a novel therapeutic strategy to restore gene expression and treat diseases, avoiding global methylation inhibitor toxicities.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Biology
Background:
- DNA methylation is a key epigenetic regulator of gene transcription and chromatin structure.
- Aberrant DNA methylation patterns are implicated in various diseases, notably cancer.
- Current DNA methylation inhibitors cause global disruption and toxicities.
Purpose of the Study:
- To review the role of DNA methylation in gene regulation and cancer.
- To explore 5-methylcytosine binding domain proteins as therapeutic targets.
- To discuss targeting protein complexes for disease treatment.
Main Methods:
- Literature review on DNA methylation.
- Analysis of 5-methylcytosine binding domain protein family functions.
- Discussion of therapeutic targeting strategies.
Main Results:
- DNA methylation is crucial for gene silencing and disease development.
- 5-methylcytosine binding domain proteins are critical readers of DNA methylation.
- Targeting these reader proteins presents a promising alternative to inhibitors.
Conclusions:
- Targeting DNA methylation readers offers a precise therapeutic approach.
- This strategy may overcome the limitations of current methylation inhibitors.
- Restoring gene expression via reader proteins holds potential for treating human diseases.
More Related Videos
13:47Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution
Published on: February 24, 2015
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
Related Concept Videos
01:37Epigenetic Regulation
X-chromosome...
01:46Epigenetic Regulation
02:23Master Transcription Regulators
01:17Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
02:25Spreading of Chromatin Modifications
Writers
The writer...